Skip to main content

Published locations for CANVAS program analysis: Canagliflozin benefits patients with T2DM and poor kidney function

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CANVAS program analysis: Canagliflozin benefits patients with T2DM and poor kidney function

User login

  • Reset your password
  • /content/canvas-program-analysis-canagliflozin-benefits-patients-t2dm-and-poor-kidney-function
  • /familypracticenews/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits-patients
  • /internalmedicinenews/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits-patients
  • /clinicalendocrinologynews/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits
  • /ecardiologynews/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits-patients-t2dm
  • /cardiology/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits-patients-t2dm-and
  • /endocrinology/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits-patients-t2dm
  • /internalmedicine/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits-patients
  • /familymedicine/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits-patients-t2dm
  • /type-2-diabetes-icymi/article/169637/diabetes/canvas-program-analysis-canagliflozin-benefits